About FDA

Office of Good Clinical Practice

The Office of Good Clinical Practice is the focal point within the Food and Drug Administration (FDA) for good clinical practice (GCP) and human subject protection (HSP) issues arising in human research trials regulated by FDA.

The Office of Good Clinical Practice:

  • Advises and assists the Commissioner and other key officials on GCP and HSP issues and policy.
  • Leads FDA's Human Subject Protection/Bioresearch Monitoring Council that manages and sets agency policy on GCP and HSP affecting clinical trials regulated by FDA.
  • Advises FDA’s Centers and the Office of Regulatory Affairs (ORA) on GCP and HSP policy and guidance relevant to the agency-wide Bioresearch Monitoring (BIMO) program for inspecting clinical investigators, sponsors, and institutional review boards (IRBs).
  • Serves as a liaison to other Federal agencies (e.g., the Department of Health and Human Services’ (HHS’) Office for Human Research Protections (OHRP), the Veterans Administration), professional organizations, regulated industry, and public interest groups on GCP and HSP policy.
  • Contributes to international GCP and HSP harmonization activities.
  • Provides advice on research ethics to FDA Centers related to medical product applications.
  • Coordinates and supports FDA compliance and enforcement activities related to the National Institutes of Health (NIH) clinical trial registration databank.
  • Plans and conducts training and outreach programs for FDA staff and external organizations.

Office of Good Clinical Practice Staff

  • Joanne R. Less, PhD, Director
  • Sheila Brown, RN, MS, Policy Analyst
  • Karena Cooper, JD, MSW, Senior Regulatory Policy Analyst
  • Janet Donnelly, RAC, Policy Analyst
  • Carol Drew, JD, Senior Regulatory Counsel
  • Bridget Foltz, MS, MT(ASCP), Policy Analyst
  • Doreen Kezer, MSN, Senior Health Policy Analyst
  • Patrick McNeilly, PhD, RPh, CIP, Senior Health Policy Analyst
  • Janet Norden, MSN, RN, Senior Regulatory Policy Advisor
  • Kevin A. Prohaska, DO, MPH, Senior Medical Policy Analyst .

Contact FDA

Office of Good Clinical Practice

Food and Drug Administration

Office of Good Clinical Practice

Office of Special Medical Programs

10903 New Hampshire Ave., WO32-5103

Silver Spring, MD 20993

Page Last Updated: 03/18/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English